BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8243289)

  • 1. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
    Furuya Y; Isaacs JT
    Endocrinology; 1993 Dec; 133(6):2660-6. PubMed ID: 8243289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.
    Furuya Y; Lin XS; Walsh JC; Nelson WG; Isaacs JT
    Endocrinology; 1995 May; 136(5):1898-906. PubMed ID: 7720636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells.
    Martikainen P; Kyprianou N; Isaacs JT
    Endocrinology; 1990 Dec; 127(6):2963-8. PubMed ID: 2249636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.
    Kyprianou N; Isaacs JT
    Mol Endocrinol; 1989 Oct; 3(10):1515-22. PubMed ID: 2608047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR; Lin XS; Isaacs JT
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
    Berges RR; Furuya Y; Remington L; English HF; Jacks T; Isaacs JT
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8910-4. PubMed ID: 8415631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen regulation of programmed death of normal and malignant prostatic cells.
    Isaacs JT; Lundmo PI; Berges R; Martikainen P; Kyprianou N; English HF
    J Androl; 1992; 13(6):457-64. PubMed ID: 1293127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An organ culture system for the study of programmed cell death in the rat ventral prostate.
    Martikainen P; Isaacs JT
    Endocrinology; 1990 Sep; 127(3):1268-77. PubMed ID: 2201533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed lineage kinase (MLK) family members are not involved in androgen regulation of prostatic proliferation or apoptosis.
    Gao J; Isaacs JT
    Prostate; 2001 Jul; 48(2):67-70. PubMed ID: 11433416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
    Kyprianou N; English HF; Isaacs JT
    Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.
    Sells SF; Wood DP; Joshi-Barve SS; Muthukumar S; Jacob RJ; Crist SA; Humphreys S; Rangnekar VM
    Cell Growth Differ; 1994 Apr; 5(4):457-66. PubMed ID: 8043520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene activity during the early phase of androgen-stimulated rat prostate regrowth.
    Katz AE; Benson MC; Wise GJ; Olsson CA; Bandyk MG; Sawczuk IS; Tomashefsky P; Buttyan R
    Cancer Res; 1989 Nov; 49(21):5889-94. PubMed ID: 2571413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.
    Furuya Y; Lundmo P; Short AD; Gill DL; Isaacs JT
    Cancer Res; 1994 Dec; 54(23):6167-75. PubMed ID: 7954463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue.
    Isaacs JT; Furuya Y; Berges R
    Semin Cancer Biol; 1994 Oct; 5(5):391-400. PubMed ID: 7849267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
    Waltregny D; Leav I; Signoretti S; Soung P; Lin D; Merk F; Adams JY; Bhattacharya N; Cirenei N; Loda M
    Mol Endocrinol; 2001 May; 15(5):765-82. PubMed ID: 11328857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of androgen action on cell proliferation: AS3 protein as a mediator of proliferative arrest in the rat prostate.
    Maffini MV; Geck P; Powell CE; Sonnenschein C; Soto AM
    Endocrinology; 2002 Jul; 143(7):2708-14. PubMed ID: 12072405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death as a new target for prostatic cancer therapy.
    Kyprianou N; Martikainen P; Davis L; English HF; Isaacs JT
    Cancer Surv; 1991; 11():265-77. PubMed ID: 1841755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.